Cargando…
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study
BACKGROUND: Fibromyalgia (FM) is a common pain condition characterized by widespread musculoskeletal pain and tenderness. Pregabalin is an approved treatment for adults in the United States, but there are no approved treatments for adolescents with FM. METHODS: This was a 15-week, randomized, double...
Autores principales: | Arnold, Lesley M., Schikler, Kenneth N., Bateman, Lucinda, Khan, Tahira, Pauer, Lynne, Bhadra-Brown, Pritha, Clair, Andrew, Chew, Marci L., Scavone, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967327/ https://www.ncbi.nlm.nih.gov/pubmed/27475753 http://dx.doi.org/10.1186/s12969-016-0106-4 |
Ejemplares similares
-
Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects
por: Zhang, Xiao, et al.
Publicado: (2021) -
Pregabalin in Treatment-Refractory Fibromyalgia
por: Stacey, Brett R, et al.
Publicado: (2010) -
Pregabalin for the management of fibromyalgia syndrome
por: Boomershine, Chad S
Publicado: (2010) -
Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
por: Arezzo, Joseph C, et al.
Publicado: (2008) -
Effect of Pregabalin on Cardiovascular Responses to Exercise and Postexercise Pain and Fatigue in Fibromyalgia: A Randomized, Double-Blind, Crossover Pilot Study
por: White, Andrea T., et al.
Publicado: (2015)